1.94
前日終値:
$1.98
開ける:
$1.96
24時間の取引高:
31,247
Relative Volume:
0.23
時価総額:
$4.22M
収益:
$10.48M
当期純損益:
$-37.74M
株価収益率:
-0.1199
EPS:
-16.1846
ネットキャッシュフロー:
$-29.03M
1週間 パフォーマンス:
-7.62%
1か月 パフォーマンス:
-16.74%
6か月 パフォーマンス:
-84.15%
1年 パフォーマンス:
-92.61%
Jaguar Health Inc Stock (JAGX) Company Profile
名前
Jaguar Health Inc
セクター
電話
415-371-8300
住所
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
JAGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
JAGX
Jaguar Health Inc
|
1.94 | 7.34M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 開始されました | Rodman & Renshaw | Buy |
Jaguar Health Inc (JAGX) 最新ニュース
News impact scoring models applied to Jaguar Health Inc.Market Sentiment Report & Daily Momentum Trading Reports - newser.com
Has Jaguar Health Inc. formed a bullish divergenceMarket Sentiment Summary & Technical Entry and Exit Tips - newser.com
How to use Fibonacci retracement on Jaguar Health Inc.July 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
How dovish Fed policy supports Jaguar Health Inc. (1JA0) stockJuly 2025 Setups & High Conviction Investment Ideas - newser.com
How hedge fund analytics apply to Jaguar Health Inc. stockWeekly Profit Report & Daily Growth Stock Investment Tips - newser.com
Will Jaguar Health Inc. benefit from macro trendsMarket Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Shelby Star
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease - Lubbock Avalanche-Journal
Can Jaguar Health Inc. stock surprise with earnings upsideQuarterly Trade Summary & Weekly Sector Rotation Insights - newser.com
Is Jaguar Health Inc. stock attractive for passive investorsPortfolio Value Summary & Weekly High Momentum Picks - newser.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Providence Journal
Will Jaguar Health Inc. stock pay special dividendsRate Cut & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-10-28 08:23:49 - fcp.pa.gov.br
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders - Corpus Christi Caller-Times
What analysts say about Jaguar Health Inc 1JA0 stockSector-Based Investing & Amplify Gains With Picks - earlytimes.in
Jaguar Health Inc (JAGX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):